316 related articles for article (PubMed ID: 22170517)
1. Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury.
Heyne N; Denecke B; Guthoff M; Oehrlein K; Kanz L; Häring HU; Weisel KC
Ann Hematol; 2012 May; 91(5):729-735. PubMed ID: 22170517
[TBL] [Abstract][Full Text] [Related]
2. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
Hutchison CA; Bradwell AR; Cook M; Basnayake K; Basu S; Harding S; Hattersley J; Evans ND; Chappel MJ; Sampson P; Foggensteiner L; Adu D; Cockwell P
Clin J Am Soc Nephrol; 2009 Apr; 4(4):745-54. PubMed ID: 19339414
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
[TBL] [Abstract][Full Text] [Related]
5. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
[TBL] [Abstract][Full Text] [Related]
7. Thirteen treated of acute renal failure secondary to multiple myeloma with high cut off filters.
Berni Wennekers A; Martín Azara MP; Dourdil Sahun V; Bergasa Liberal B; Ruiz Laiglesia JE; Vernet Perna P; Alvarez Lipe R
Nefrologia; 2016; 36(4):418-26. PubMed ID: 27255910
[TBL] [Abstract][Full Text] [Related]
8. Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
Steiner N; Abdel Hamid A; Kronbichler A; Neuwirt H; Myslivecek M; Kollar M; Lachmanova J; Rysava R; Hruskova Z; Spicka I; Willenbacher W; Nachbaur D; Wolf D; Tesar V; Gunsilius E
J Nephrol; 2021 Aug; 34(4):1263-1270. PubMed ID: 33382447
[TBL] [Abstract][Full Text] [Related]
9. Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study.
Gerth HU; Pohlen M; Görlich D; Thölking G; Kropff M; Berdel WE; Pavenstädt H; Brand M; Kümpers P
PLoS One; 2016; 11(5):e0154993. PubMed ID: 27152520
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
11. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Yadav P; Hutchison CA; Basnayake K; Stringer S; Jesky M; Fifer L; Snell K; Pinney J; Drayson MT; Cook M; Cockwell P
Eur J Haematol; 2016 Jun; 96(6):610-7. PubMed ID: 26248588
[TBL] [Abstract][Full Text] [Related]
12. Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.
Kleeberg L; Morgera S; Jakob C; Hocher B; Schneider M; Peters H; Rötzer S; Müller C; Kaiser M; Fleissner C; Heider U; Neumayer HH; Sezer O
Eur J Med Res; 2009; 14(2):47-54. PubMed ID: 19258212
[TBL] [Abstract][Full Text] [Related]
13. Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney.
Donati G; Zappulo F; Maietti E; Scrivo A; Gasperoni L; Zamagni E; Tacchetti P; Pantani L; Baraldi O; Comai G; Cappuccilli M; Cavo M; La Manna G
Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737052
[TBL] [Abstract][Full Text] [Related]
14. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
Bridoux F; Carron PL; Pegourie B; Alamartine E; Augeul-Meunier K; Karras A; Joly B; Peraldi MN; Arnulf B; Vigneau C; Lamy T; Wynckel A; Kolb B; Royer B; Rabot N; Benboubker L; Combe C; Jaccard A; Moulin B; Knebelmann B; Chevret S; Fermand JP;
JAMA; 2017 Dec; 318(21):2099-2110. PubMed ID: 29209721
[TBL] [Abstract][Full Text] [Related]
15. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Psimenou E; Eleutherakis-Papaiakovou E; Migkou M; Matsouka C; Mparmparousi D; Gika D; Kafantari E; Ziogas D; Fotiou D; Panagiotidis I; Terpos E; Kastritis E
Am J Hematol; 2016 May; 91(5):499-502. PubMed ID: 26890495
[TBL] [Abstract][Full Text] [Related]
18. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
[TBL] [Abstract][Full Text] [Related]
19. Reversible acute kidney injury (AKI) by active removal of serum light chains in an HIV positive patient with myeloma kidney.
Sowole L; Burns A; Kaur B; Davenport A
Clin Nephrol; 2011 Nov; 76(5):417-20. PubMed ID: 22000564
[TBL] [Abstract][Full Text] [Related]
20. High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series.
Heyne N; Guthoff M; Krieger J; Haap M; Häring HU
Nephron Clin Pract; 2012; 121(3-4):c159-64. PubMed ID: 23327834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]